Clarius Group Portfolio holdings
Clarius Group is a multi-family office that serves ultra-high-net-worth individuals and families. It provides investment advice, family office services and personal accounting. Keith Vernon and Matthew Talbot are among its founding partners. Clearstead Advisors, an investment adviser, bought the firm in a deal that closed in January 2026.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.86M |
| 2 |
ESL
Esterline Technologies
ESL
|
+$1.35M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$1.25M |
| 4 |
KITE
Kite Pharma, Inc.
KITE
|
+$268K |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$197K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Impinj
PI
|
+$2.05M |
| 2 |
Sage Therapeutics
SAGE
|
+$1.57M |
| 3 |
Apple
AAPL
|
+$1.43M |
| 4 |
Amazon
AMZN
|
+$1.26M |
| 5 |
Microsoft
MSFT
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 38.26% |
| 2 | Miscellaneous | 27.03% |
| 3 | Consumer Discretionary | 14.01% |
| 4 | Healthcare | 9.82% |
| 5 | Technology | 4.99% |
Similar funds
Clarius Group's Q3 2017 Portfolio in Review
As of Q3 2017, Clarius Group held 100 positions worth $238M, down 2.1% from $243M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Clarius Group withdrew a net $16.6M in Q3 2017, closing 30 positions and reducing 37 holdings. Its most notable exit was bluebird bio, an estimated $765K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 35% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
Against the trend, Clarius Group opened a new position in Berkshire Hathaway Class A worth $1.92M.
- Clarius Group's largest Q3 2017 buy was Berkshire Hathaway Class A: 7 shares worth $1.92M.
- Clarius Group added most to Vanguard Morningstar Value ETF in Q3 2017, an estimated $1.25M increase.
- Clarius Group's biggest Q3 2017 reduction was Impinj, cutting an estimated $2.05M.
- Clarius Group fully exited bluebird bio in Q3 2017, selling an estimated $765K.
- Clarius Group's ten largest holdings make up 74% of its $238M portfolio in Q3 2017.
- Clarius Group opened 5 new positions and closed 30 in Q3 2017.
- Clarius Group's portfolio value fell 2.1% quarter-over-quarter to $238M.
Based on Clarius Group's 13F filing for Q3 2017, filed 7 Nov 2017.